Argonautica Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Argonautica Private Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$470K	Buy	3,371 +143	+4%	+$20K	0.14%	134
2025 Q4	$396K	Sell	3,228 -197	-6%	-$23.9K	0.12%	144
2025 Q3	$380K	Hold	3,425	–	–	0.11%	146
2025 Q2	$380K	Sell	3,425 -431	-11%	-$45.9K	0.12%	144
2025 Q1	$432K	Sell	3,856 -253	-6%	-$26.1K	0.15%	126
2024 Q4	$380K	Sell	4,109 -67	-2%	-$6.03K	0.12%	137
2024 Q3	$350K	Buy	4,176 +8	+0.2%	+$610	0.12%	148
2024 Q2	$286K	Sell	4,168 -35,304	-89%	-$2.36M	0.1%	164
2024 Q1	$2.89M	Buy	39,472 +1,398	+4%	+$108K	1.04%	25
2023 Q4	$3.08M	Sell	38,074 -165	-0.4%	-$12.8K	1.26%	21
2023 Q3	$2.87M	Buy	38,239 +120	+0.3%	+$9.23K	1.29%	20
2023 Q2	$2.94M	Buy	38,119 +634	+2%	+$50.6K	1.32%	20
2023 Q1	$3.11M	Sell	37,485 -2,429	-6%	-$201K	1.57%	15
2022 Q4	$3.43M	Buy	+39,914	New	+$3.16M	1.76%	13

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Argonautica Private Wealth Management's GILD Position: Q1 2026 in Review

Argonautica Private Wealth Management increased its Gilead Sciences (GILD) stake by 4.4% in Q1 2026, buying an estimated $20K and bringing the position to 3,371 shares worth $470K. The position accounts for 0.14% of the portfolio, ranked #134.

Argonautica Private Wealth Management first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.43M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Argonautica Private Wealth Management held 3,371 shares of Gilead Sciences worth $470K as of Q1 2026.
Argonautica Private Wealth Management bought 143 Gilead Sciences shares in Q1 2026, an estimated $20K.
Gilead Sciences made up 0.14% of Argonautica Private Wealth Management's portfolio in Q1 2026, its #134 holding.
Argonautica Private Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
Argonautica Private Wealth Management's Gilead Sciences position peaked at $3.43M in Q4 2022.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.